Interestingly, it has been recently shown that misfolded ATF6 needs SEL1L for degradation despite the transmembrane nature of ATF6 (83), which indicates that degradation pathways are much more diversified than expected in eukaryotes, but with a still unknown role in cancer biology. The gene discussed is ATF6; the disease is cancer.